image
Stoke Therapeutics, Inc. STOK
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 12.03
-13.6 %
$ 637 M
Market Cap
-5.78
P/E
BALANCE SHEET
228 M ASSETS
-10.83%
Growth Rates
1Year -10.83%
3Years -8.48%
5Years 16.25%
7Years 0.00%
10Years 0.00%
68.8 M LIABILITIES
-3.43%
Growth Rates
1Year -3.43%
3Years 79.73%
5Years 94.50%
7Years 0.00%
10Years 0.00%
160 M EQUITY
-13.68%
Growth Rates
1Year -13.68%
3Years -17.68%
5Years 8.72%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Stoke Therapeutics, Inc.
image
Current Assets 215 M
Cash & Short-Term Investments 201 M
Receivables 64 K
Other Current Assets 13.9 M
Non-Current Assets 13 M
Long-Term Investments 0
PP&E 12.4 M
Other Non-Current Assets 569 K
Current Liabilities 30.8 M
Accounts Payable 1.7 M
Short-Term Debt 2.06 M
Other Current Liabilities 27.1 M
Non-Current Liabilities 38 M
Long-Term Debt 0
Other Non-Current Liabilities 38 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 191.4 113.6 144.9 287.3 222.5 105.4 1.8
Short Term Investments 10.0 116.0 74.9 0 0 0 0
Receivables 64 K 0.6 0.1 6 K 0.3 0.2 0
Inventory 0 10.9 0 0 0 0 0
Other Current Assets 13.9 13.9 9.3 6.6 6.6 0.5 0.1
Total Current Assets 215.3 244.1 229.2 293.9 226.0 106.1 1.9
PP&E 12.4 11.4 9.1 3.8 2.5 1.2 0.5
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0.6 0.6 0.2 0.2 0.2 56 K
Other Long Term Assets 0.6 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0
Total Assets 228.3 256.1 238.9 297.9 228.8 107.5 2.4
LIABILITIES
Accounts Payable 1.7 0.8 2.4 1.5 0.8 1.1 0.1
Short Term Debt 2.1 2.4 1.5 1.1 0 0 3.0
Other Current Liabilities 11.8 13.4 13.2 8.9 3.4 1.4 0.6
Total Current Liabilities 30.8 31.4 17.1 11.4 4.1 2.5 3.7
Long Term Debt 0 0 0 0 0 0 0
Deferred Tax Income 0 (2.7) 0 0 0 0 0
Other Liabilities 38.0 3.0 3.9 0.4 0.2 4 K 16 K
Total Liabilities 68.8 71.2 21.1 11.8 4.3 2.5 3.7
EQUITY
Common Stock 5 K 4 K 4 K 4 K 3 K 1 K 1 K
Retained Earnings (401.8) (297.1) (196.1) (110.3) (58.0) (25.7) (13.2)
Other Accumulative Comprehensive Income/Loss 24 K (1.2) (0.2) 0 0 (0.4) (0.2)
Total Equity 159.6 184.8 217.8 286.1 224.4 105.1 (1.3)
Total Liabilities and Equity 228.3 256.1 238.9 297.9 228.8 107.5 2.4
SHARES OUTSTANDING
Common Shares Outstanding 44.0 38.9 36.7 33.5 18.0 23.5 12.8